These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37167414)

  • 1. Photoswitchable Inhibitors to Optically Control Specific Kinase Activity.
    Aguirre T; Teichmann E; Römpp FQ; Vivier R; Bryant C; Hulverson MA; Van Voorhis WC; Ojo KK; Doggett JS; Fiedler D; Hecht S
    ACS Chem Biol; 2023 Jun; 18(6):1378-1387. PubMed ID: 37167414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1.
    Larson ET; Ojo KK; Murphy RC; Johnson SM; Zhang Z; Kim JE; Leibly DJ; Fox AM; Reid MC; Dale EJ; Perera BG; Kim J; Hewitt SN; Hol WG; Verlinde CL; Fan E; Van Voorhis WC; Maly DJ; Merritt EA
    J Med Chem; 2012 Mar; 55(6):2803-10. PubMed ID: 22369268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1.
    Zhang Z; Ojo KK; Johnson SM; Larson ET; He P; Geiger JA; Castellanos-Gonzalez A; White AC; Parsons M; Merritt EA; Maly DJ; Verlinde CL; Van Voorhis WC; Fan E
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5264-7. PubMed ID: 22795629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture.
    Kuhlenschmidt TB; Rutaganira FU; Long S; Tang K; Shokat KM; Kuhlenschmidt MS; Sibley LD
    Antimicrob Agents Chemother; 2016 Jan; 60(1):570-9. PubMed ID: 26552986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii.
    Rutaganira FU; Barks J; Dhason MS; Wang Q; Lopez MS; Long S; Radke JB; Jones NG; Maddirala AR; Janetka JW; El Bakkouri M; Hui R; Shokat KM; Sibley LD
    J Med Chem; 2017 Dec; 60(24):9976-9989. PubMed ID: 28933846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned.
    Choi R; Hulverson MA; Huang W; Vidadala RSR; Whitman GR; Barrett LK; Schaefer DA; Betzer DP; Riggs MW; Doggett JS; Hemphill A; Ortega-Mora LM; McCloskey MC; Arnold SLM; Hackman RC; Marsh KC; Lynch JJ; Freiberg GM; Leroy BE; Kempf DJ; Choy RKM; de Hostos EL; Maly DJ; Fan E; Ojo KK; Van Voorhis WC
    Int J Parasitol; 2020 May; 50(5):413-422. PubMed ID: 32224121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
    Ojo KK; Dangoudoubiyam S; Verma SK; Scheele S; DeRocher AE; Yeargan M; Choi R; Smith TR; Rivas KL; Hulverson MA; Barrett LK; Fan E; Maly DJ; Parsons M; Dubey JP; Howe DK; Van Voorhis WC
    Int J Parasitol; 2016 Dec; 46(13-14):871-880. PubMed ID: 27729271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by Toxoplasma gondii.
    Lourido S; Zhang C; Lopez MS; Tang K; Barks J; Wang Q; Wildman SA; Shokat KM; Sibley LD
    J Med Chem; 2013 Apr; 56(7):3068-77. PubMed ID: 23470217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.
    Johnson SM; Murphy RC; Geiger JA; DeRocher AE; Zhang Z; Ojo KK; Larson ET; Perera BG; Dale EJ; He P; Reid MC; Fox AM; Mueller NR; Merritt EA; Fan E; Parsons M; Van Voorhis WC; Maly DJ
    J Med Chem; 2012 Mar; 55(5):2416-26. PubMed ID: 22320388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
    Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
    J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift Assays.
    Scheele S; Geiger JA; DeRocher AE; Choi R; Smith TR; Hulverson MA; Vidadala RSR; Barrett LK; Maly DJ; Merritt EA; Ojo KK; Van Voorhis WC; Parsons M
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Activity of Mutant Calcium-Dependent Protein Kinase 1 Is Compensated in Plasmodium falciparum through the Action of Protein Kinase G.
    Bansal A; Ojo KK; Mu J; Maly DJ; Van Voorhis WC; Miller LH
    mBio; 2016 Dec; 7(6):. PubMed ID: 27923926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and selective inhibitors of CDPK1 from
    Zhang Z; Ojo KK; Vidadala R; Huang W; Geiger JA; Scheele S; Choi R; Reid MC; Keyloun KR; Rivas K; Siddaramaiah LK; Comess KM; Robinson KP; Merta PJ; Kifle L; Hol WG; Parsons M; Merritt EA; Maly DJ; Verlinde CL; Van Voorhis WC; Fan E
    ACS Med Chem Lett; 2014 Jan; 5(1):40-44. PubMed ID: 24494061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.
    Ojo KK; Larson ET; Keyloun KR; Castaneda LJ; Derocher AE; Inampudi KK; Kim JE; Arakaki TL; Murphy RC; Zhang L; Napuli AJ; Maly DJ; Verlinde CL; Buckner FS; Parsons M; Hol WG; Merritt EA; Van Voorhis WC
    Nat Struct Mol Biol; 2010 May; 17(5):602-7. PubMed ID: 20436472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel acyl carbamates and acyl / diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum.
    Li K; Grooms GM; Khan SM; Hernandez AG; Witola WH; Stec J
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():80-90. PubMed ID: 33011650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase.
    Donald RG; Zhong T; Wiersma H; Nare B; Yao D; Lee A; Allocco J; Liberator PA
    Mol Biochem Parasitol; 2006 Sep; 149(1):86-98. PubMed ID: 16765465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the kinase inhibitor analog 1NM-PP1 reveals a role for Toxoplasma gondii CDPK1 in the invasion step.
    Sugi T; Kato K; Kobayashi K; Watanabe S; Kurokawa H; Gong H; Pandey K; Takemae H; Akashi H
    Eukaryot Cell; 2010 Apr; 9(4):667-70. PubMed ID: 20173034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis.
    Janetka JW; Hopper AT; Yang Z; Barks J; Dhason MS; Wang Q; Sibley LD
    J Med Chem; 2020 Jun; 63(11):6144-6163. PubMed ID: 32420739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma DJ-1 Regulates Organelle Secretion by a Direct Interaction with Calcium-Dependent Protein Kinase 1.
    Child MA; Garland M; Foe I; Madzelan P; Treeck M; van der Linden WA; Oresic Bender K; Weerapana E; Wilson MA; Boothroyd JC; Reese ML; Bogyo M
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.